Wells Fargo & Company Cuts Omega Healthcare Investors (NYSE:OHI) Price Target to $48.00

Omega Healthcare Investors (NYSE:OHIGet Free Report) had its target price decreased by investment analysts at Wells Fargo & Company from $49.00 to $48.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 2.33% from the company’s previous close.

Several other equities research analysts have also recently commented on the stock. Scotiabank dropped their target price on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Citigroup increased their price target on shares of Omega Healthcare Investors from $52.00 to $58.00 and gave the stock a “buy” rating in a research note on Tuesday, August 4th. Raymond James Financial assumed coverage on shares of Omega Healthcare Investors in a report on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 price objective for the company. Royal Bank Of Canada lifted their price objective on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research report on Monday, May 4th. Finally, UBS Group set a $47.00 target price on Omega Healthcare Investors in a report on Thursday, June 18th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $49.50.

View Our Latest Stock Analysis on Omega Healthcare Investors

Omega Healthcare Investors Trading Up 2.6%

Shares of OHI stock traded up $1.19 during trading hours on Tuesday, reaching $46.91. The company’s stock had a trading volume of 330,188 shares, compared to its average volume of 2,068,946. Omega Healthcare Investors has a one year low of $39.26 and a one year high of $52.39. The stock has a market capitalization of $14.21 billion, a P/E ratio of 16.75, a P/E/G ratio of 1.86 and a beta of 0.57. The firm’s fifty day simple moving average is $48.36 and its 200 day simple moving average is $47.10.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.68. The company had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The firm’s revenue was up 16.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, equities research analysts forecast that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OHI. Resources Management Corp CT ADV boosted its stake in shares of Omega Healthcare Investors by 300.0% in the 4th quarter. Resources Management Corp CT ADV now owns 600 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 450 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Omega Healthcare Investors by 40.9% during the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 268 shares during the last quarter. Ascentis Independent Advisors purchased a new position in shares of Omega Healthcare Investors in the first quarter worth approximately $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new stake in Omega Healthcare Investors during the fourth quarter valued at approximately $37,000. Finally, Rothschild Investment LLC raised its position in Omega Healthcare Investors by 283.7% in the fourth quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust’s stock worth $42,000 after acquiring an additional 698 shares during the period. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Featured Articles

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.